Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |